US Stock MarketDetailed Quotes

CARA Cara Therapeutics

Watchlist
  • 0.308
  • +0.003+0.92%
Trading Nov 21 14:22 ET
16.88MMarket Cap-175P/E (TTM)

Cara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.200M--
--2024/Q4-- / 1.596M--
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.200M--
--2024/Q4-- / 1.596M--
--2024/Q32.556M / 1.616M--
--2024/Q2991.000K / 1.174M--
May 13, 20242024/Q12.135M / 1.690M--

Unlock Free Earnings Estimates

Cara Therapeutics Earnings Reports

  • Cara Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 16:17 ET

  • Cara Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 16:16 ET

  • Cara Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 13 16:20 ET

  • Cara Therapeutics | 10-K: FY2023 Annual Report

    Mar 6 16:22 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data